JERUSALEM, March 27( Xinhua)--An Israeli-led research team has developed a potential new treatment for head and neck cancer( HNC), using a targeted drug and immunotherapy, Ben Gurion University( BGU) in southern Israel announced on Sunday. The findings, co-authored by Israeli, Chinese, French, German and U.S. researchers, were published in the Journal for ImmunoTherapy of Cancer on Sunday. Through pre-clinical study, the researchers found a new treatment combination of Trametinib, a cancer drug
综合
星报-世界
2022-03-28 00:00:00.0